Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 6/22/26 | Sumitovant Biopharma | Myfembree for Uterine Fibroids | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/22/26 | Haisco (002653) | HSK39297 for Paroxysmal Nocturnal Hemoglobinuria (PNH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/22/26 | Haisco (002653) | HSK39297 for Paroxysmal Nocturnal Hemoglobinuria (PNH) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/21/26 | MoonLake (MLTX) | sonelokimab for Hidradenitis Suppurativa | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/21/26 | MoonLake (MLTX) | sonelokimab for Hidradenitis Suppurativa | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/26/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/08/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/17/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |